Atractylodin inhibits fructose-induced human podocyte hypermotility via anti-oxidant to down-regulate TRPC6/p-CaMK4 signaling
Article in European Journal of Pharmacology (November 2021)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Article in European Journal of Pharmacology (November 2021)
Article in Expert Review of Cardiovascular Therapy (December 2019)
Article in Scientific Reports (April 2018)